Skip to product information
1 of 1

Elabscience

SKU:PKSV030394

Recombinant SARS-CoV-2 Spike S2 (E780Q)(ECD, His Tag)

Recombinant SARS-CoV-2 Spike S2 (E780Q)(ECD, His Tag)

Regular price $1,105.00 USD
Regular price Sale price $1,105.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant SARS-CoV-2 Spike S2 (E780Q)(ECD, His Tag), a cutting-edge product meticulously designed to cater to the ever-evolving demands of the scientific community. This exceptional offering showcases a recombinant form of the SARS-CoV-2 Spike S2 protein, featuring the E780Q mutation, coupled with an engineered C-terminal domain (ECD) and a His tag for enhanced versatility and ease of use.

Crafted with utmost precision, this product embodies the epitome of scientific advancement, enabling researchers to delve deeper into the intricate mechanisms of the SARS-CoV-2 virus. The incorporation of the E780Q mutation within the Spike S2 protein confers a unique characteristic, augmenting the potential for comprehensive investigations into viral behavior and host interactions.

The engineered C-terminal domain (ECD) further amplifies the utility of this product, facilitating a wide range of experimental applications. Researchers can harness its potential to unravel the mysteries surrounding viral entry, fusion, and other critical processes, thereby paving the way for groundbreaking discoveries in the field of virology.

To ensure utmost convenience and compatibility, this recombinant protein is equipped with a His tag, enabling facile purification and detection. This feature streamlines experimental workflows, saving valuable time and resources, while maintaining the integrity and purity of the protein.

The Recombinant SARS-CoV-2 Spike S2 (E780Q)(ECD, His Tag) epitomizes excellence in scientific innovation, offering an unparalleled opportunity to unravel the complexities of the SARS-CoV-2 virus. With its exceptional design, this product empowers researchers to push the boundaries of knowledge, fostering advancements in the fight against the global pandemic.
View full details